Paranoia
8
3
3
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (8)
Racial Disparities in the Expression of Paranoia
Acceptability and Feasibility of a Brief Paranoia Intervention.
Supporting Patients by Family Education in Psychotic Illness: A Prospective Cohort Study
TReating Unhelpful Suspicious Thoughts in Adolescents (TRUST): a School-based Case Series
Recovery From Paranoia: a Qualitative Exploration
Virtual Reality Assisted CBT for Social Difficulties: a Feasibility Study in Early Intervention for Psychosis Services
The Street Smart Group: A Feasibility Trial of a Group Intervention Targeting Anxiety Processes in Paranoia
Oxytocin Treatment of Schizophrenia